The future of shared services is already unfolding—and pharma is leading the way.
Across the pharmaceutical sector, Global Shared Services (GSS) is undergoing a quiet revolution. Not driven by headcount or outsourcing—but by artificial intelligence.
From cost savings to compliance automation, pharma giants like AstraZeneca and GSK are proving that AI isn’t just hype—it’s delivering serious ROI.
AstraZeneca: Redefining IT and Compliance with AI
AstraZeneca took a bold step to reduce its IT cost footprint, which was consuming nearly 5% of its total revenue. Through AI-driven IT optimization, they brought this down to just 3%.
Even more impressive is how they tackled compliance:
- Reduced compliance costs by 50% in just 3 months
- Handled 80% of repetitive regulatory queries
- Achieved 90% accuracy with 98% trigger rates
- Freed up a team of 12 compliance officers to focus on high-value work
GSK: Smart Manufacturing and AI-Driven Decisions
While AstraZeneca led in compliance, GSK focused on smart manufacturing. By integrating AI and machine learning into their production facilities, they:
- Streamlined batch production
- Automated regulatory documentation
- Enabled faster, data-informed decisions
GSK’s responsible AI strategy ensures they meet patient needs and regulatory demands with speed and accuracy.
AI Adoption in Pharma Is Scaling Fast
- 95% of pharmaceutical firms are now investing in AI
- AI spend in pharma projected to grow from $4B to $25B by 2030
- 40% of pharma execs already budgeting for AI-driven cost savings in 2024
AI is no longer just R&D—it’s now core to business operations.
Where AI Makes the Biggest Impact in Shared Services
- Document Processing: 70% cost reduction in clinical trial document management
- Compliance Automation: 80%+ of queries handled by bots
- Customer Support: AI chatbots resolving thousands of employee requests weekly
- Ops Optimization: Manual effort reduced by 30–50%
Real Outcomes, Real Savings
- 20% decrease in operating costs
- 30–80% faster service processing
- Happier teams due to reduced grunt work
- Strategic focus enabled across departments
What’s Your Organization’s AI Game Plan?
Pharma isn’t experimenting anymore—it’s scaling.
If AstraZeneca and GSK can reimagine shared services through AI, what’s stopping your business from doing the same?
At DataMoo.ai, we help enterprises unlock the full potential of AI across operations, compliance, and experience delivery.
Ready to scale your shared services with AI?
